NCT06147232: Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia
- State
- Not started
- Phase
- Phase 2
- People
- 69 planned
- Started
- Feb 2025
- Primary completion
- May 2027
- Arms
- order: placebo/sotagliflozin, order: sotagliflozin/placebo
- Results
- None posted
- 27 Nov 2023: Trial registered